You are here: Industry Insights > Sun Pharmaceutical

News List

Sun Pharma receives Japan MHLW approval of ILUMYATM for the treatment of Plaque Psoriasis expresspharma
June 30, 2020
ILUMYA is one of the key specialty products of Sun Pharma and it was approved by US FDA in March 2018 while the European Commission approved it in September 2018.
Sun Pharma gets DCGI nod for clinical trial with Nafamostat in COVID-19 patients expresspharma
June 01, 2020
Nafamostat is identified as a potential candidate for COVID-19 patients by scientists at the University of Tokyo and Leibniz Institute for Primate Research, Germany.
US FDA classifies Sun Pharma’s Halol facility as official action indicated expresspharma
March 31, 2020
Drug major Sun Pharmaceutical on Sunday said the US health regulator has classified its Halol facility in Gujarat as Official Action Indicated (OAI).
Sun Pharmaceutical Issues Voluntary Nationwide Recall of Vecuronium americanpharmaceuticalreview
January 09, 2019
Sun Pharmaceutical is voluntarily recalling three lots of Vecuronium Bromide for Injection, 10 mg (lyophilized powder), and one lot of Vecuronium Bromide for Injection....
Sun gets dermatology portfolio, 2 plants in Japan with Pola Pharma deal fiercepharma
December 10, 2018
Sun Pharma got a start in Japan when it paid Novartis nearly $300 million a couple of years ago for more than a dozen drugs the Swiss drugmaker was unloading.
Mismanagement allegations send Sun Pharma stock tumbling: What we know so far fiercepharma
December 06, 2018
Sun Pharma managing director Dilip Shangvhi went into crisis mode Tuesday after shares slid on worries about a potential government investigation, reports of insider dealing...
Sun Pharmaceutical agrees to acquire Japan’s Pola Pharma pharmaceutical
November 29, 2018
India-based drugmaker Sun Pharmaceutical Industries has signed a definitive agreement to acquire Pola Pharma, a Japan-based pharma firm involved in the research, development, manufacture, and sale of branded and generic products......
FDA Approves Yonsa drugs
May 31, 2018
Sun Pharmaceutical Industries Ltd. and includes its subsidiaries and/or associate companies) and Churchill Pharmaceuticals, LLC.